浏览全部资源
扫码关注微信
血浆Septin9基因甲基化状态和水平在胃癌患者诊断和预后评估中的应用价值
Expression of plasma methylated
Septin 9 gene and its clinical significance in patients with gastric cancer- 中国癌症杂志 2023年33卷第2期 页码：162-167
- 作者机构：
1. 复旦大学附属中山医院检验科，上海 200032
2. 复旦大学附属中山医院厦门医院检验科，福建 厦门 361015
- 作者简介：
[ "陈馨宁（ORCID: 0000-0002-2614-6003），本科，技师。" ]
张春燕（ORCID: 0000-0002-0345-6236），硕士，副主任技师，主任。
- 基金信息：国家自然科学基金(81972000);国家自然科学基金(82172348);复旦大学附属中山医院临床研究专项基金(2018ZSLC05);国家自然科学基金青年项目(81902139);复旦大学附属中山医院临床研究专项基金(2020ZSLC54);上海市临床重点专科建设项目(shslczdzk03302);上海市医学重点专科项目(ZK2019B28);厦门市医疗卫生重点项目(YDZX20193502000002);复旦大学附属中山医院青年基金(2021ZSQN38)
DOI：10.19401/j.cnki.1007-3639.2023.02.009
中图分类号： R735.2收稿：2022-06-24，
修回：2022-10-13，
纸质出版：2023-02-28
- 稿件说明：
移动端阅览
陈馨宁, 姜惠琴, 杨轶慧, 等. 血浆Septin9基因甲基化状态和水平在胃癌患者诊断和预后评估中的应用价值[J]. 中国癌症杂志, 2023,33(2):162-167.
Xinning CHEN, Huiqin JIANG, Yihui YANG, et al. Expression of plasma methylated
Septin 9 gene and its clinical significance in patients with gastric cancer[J]. China Oncology, 2023, 33(2): 162-167.陈馨宁, 姜惠琴, 杨轶慧, 等. 血浆Septin9基因甲基化状态和水平在胃癌患者诊断和预后评估中的应用价值[J]. 中国癌症杂志, 2023,33(2):162-167. DOI： 10.19401/j.cnki.1007-3639.2023.02.009.
Xinning CHEN, Huiqin JIANG, Yihui YANG, et al. Expression of plasma methylated
Septin 9 gene and its clinical significance in patients with gastric cancer[J]. China Oncology, 2023, 33(2): 162-167. DOI： 10.19401/j.cnki.1007-3639.2023.02.009.
摘要
背景与目的：
胃癌是中国常见的恶性肿瘤之一，胃癌诊疗过程中仍缺乏高特异性、高灵敏度的生物标志物。甲基化的
Septin
9基因（methylated
Septin
9 gene，m
SEPT
9）在胃癌患者癌组织中特征性增高。本文旨在探讨胃癌患者血浆m
SEPT
9的表达及临床意义。
方法：
纳入2020年4月—11月在复旦大学附属中山医院检验科检测血浆m
SEPT
9（PCR荧光探针法）的221例诊断为胃癌的患者以及34例无疾病证据受检者，并应用ΔΔCt法对m
SEPT
9水平进行相对定量。收集相关临床资料，包括临床病理学资料（患者基本信息和病理学检查结果）和血清蛋白标志物[癌胚抗原（carcinoembryonic antigen，CEA）、糖类抗原（carbohydrate antigen，CA）12-5、CA19-9和CA72-4
]
并采用配对
t
检验、
χ
2
检验和受试者工作特征（receiver operating characteristic，ROC）曲线进行分析。
结果：
m
SEPT
9在胃癌未治疗人群中的阳性率为35%（28/80），曲线下面积（area under curve，AUC）为0.815 3，灵敏度为35%，特异度为100%。脉管内见癌栓、侵及浆膜层或周围组织和存在淋巴结转移的胃癌患者术前mSEPT9阳性率较高（46.87%
vs
12.50%，45.16%
vs
14.29%，75.00%
vs
40.00%），差异均有统计学意义（
P
<
0.05）。治疗后疾病进展（progressive disease，PD）患者mSEPT9阳性率高于治疗后部分缓解（partial response，PR）和稳定（stable disease，SD）患者（68.75%
vs
17.74%），差异有统计学意义（
P
<
0.05）。患者疾病进展前和疾病进展时m
SEPT
9 ΔΔCt差异均有统计学意义（
P
<
0.05）。
结论：
血浆m
SEPT9
基因检测在胃癌诊断中的灵敏度和特异性较传统血清蛋白标志物（CEA、CA12-5、CA19-9和CA72-4）更优。该标志物能提供严重程度相关信息，且在PD患者中阳性率较高。
SEPT9
状态和相对定量结果在预测术后病理学分期和治疗反应中具有潜在临床意义。
Abstract
Background and purpose:
Gastric cancer is one of the most common malignant tumors in our country. The diagnosis and treatment process of gastric cancer lacks of sensitive and specific biomarker. This study aimed to explore the expression of plasma methylated
Septin
9 gene (
mSEPT
9) and its clinical significance in patients with gastric cancer.
Methods:
From April 2020 to November 2020
221 patients with gastric cancer and 34 patients with no evidence of disease who visited Zhongshan Hospital Fudan University were enrolled. The status of m
SEPT
9 was detected by polymerase chain reaction (PCR) fluorescence probe method
and relative m
SEPT
9 value was determined by the ΔΔCt method. Detailed clinical data including pathological characteristics (patients characteristics and pathology characteristics) and serum biomarkers [carcinoembryonic antigen (CEA)
carbohydrate antigen (CA)12-5
CA19-9 and CA72-4
]
were collected and analyzed. Paired
t
test
χ
2
test and receiver operating characteristic (ROC) curve analysis were performed for statistical analysis.
Results:
The positive rate
sensitivity and specificity of plasma m
SEPT
9 were 35%
35% and 100%
respectively in untreated patients with gastric cancer. The positive rate of m
SEPT
9 was higher in patients with blood vessel invasion
serosa invasion and lymphatic metastasis
which was 46.87%
vs
12.50%
45.16%
vs
14.29%
75.00%
vs
40.00%
respectively (
P
<
0.05). The positive rate of m
SEPT
9 was higher in progressive disease (PD) patients
than in partial response (PR) and stable disease (SD) patients
which were 68.75% and 17.74%
the differences were statistically significant (
P
<
0.05). mSEPT9 level before PD and at the time of PD showed statistically significance.
Conclusion:
Plasma m
SEPT
9 detection demonstrates a more satisfactory diagnostic performance in gastric cancer than traditional serum biomarkers. The biomarker can provide information regarding severity with high positive rate among PD patients. The status and level of m
SEPT
9 were of clinical significance in evaluating tumor burden and predicting treatment response.
关键词
Keywords
references
SUNG H , FERLAY J , SIEGEL R L , et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 . DOI: 10.3322/caac.v71.3 http://doi.org/10.3322/caac.v71.3 https://onlinelibrary.wiley.com/toc/15424863/71/3 https://onlinelibrary.wiley.com/toc/15424863/71/3
GBD STOMACH CANCER COLLABORATORS . The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the global burden of disease study 2017 [J ] . Lancet Gastroenterol Hepatol , 2020 , 5 ( 1 ): 42 - 54 . DOI: 10.1016/S2468-1253(19)30328-0 http://doi.org/10.1016/S2468-1253(19)30328-0 https://linkinghub.elsevier.com/retrieve/pii/S2468125319303280 https://linkinghub.elsevier.com/retrieve/pii/S2468125319303280
KLUTSTEIN M , NEJMAN D , GREENFIELD R , et al. DNA methylation in cancer and aging [J ] . Cancer Res , 2016 , 76 ( 12 ): 3446 - 3450 . DOI: 10.1158/0008-5472.CAN-15-3278 http://doi.org/10.1158/0008-5472.CAN-15-3278
李楠 , 王贺玲 , 梁晓平 , 等 . SEPTIN 9在胃癌组织中的表达及临床意义 [J ] . 中国微创外科杂志 , 2014 , 14 ( 12 ): 1125 - 1127 .
LI N , WANG H L , LIANG X P , et al. Expression of SEPTIN 9 in gastric cancer tissues and its clinical significance [J ] . Chin J Minim Invasive Surg , 2014 , 14 ( 12 ): 1125 - 1127 .
CESCON D W , BRATMAN S V , CHAN S M , et al. Circulating tumor DNA and liquid biopsy in oncology [J ] . Nat Cancer , 2020 , 1 ( 3 ): 276 - 290 . DOI: 10.1038/s43018-020-0043-5 http://doi.org/10.1038/s43018-020-0043-5
LUO H Y , WEI W , YE Z Y , et al. Liquid biopsy of methylation biomarkers in cell-free DNA [J ] . Trends Mol Med , 2021 , 27 ( 5 ): 482 - 500 . DOI: 10.1016/j.molmed.2020.12.011 http://doi.org/10.1016/j.molmed.2020.12.011
DIETRICH D , HASINGER O , LIEBENBERG V , et al. DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small cell lung cancer patients [J ] . Diagn Mol Pathol , 2012 , 21 ( 2 ): 93 - 104 . DOI: 10.1097/PDM.0b013e318240503b http://doi.org/10.1097/PDM.0b013e318240503b http://journals.lww.com/00019606-201206000-00005 http://journals.lww.com/00019606-201206000-00005
DE VOS L , GEVENSLEBEN H , SCHRÖCK A , et al. Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients [J ] . Clin Epigenetics , 2017 , 9 : 125 . DOI: 10.1186/s13148-017-0425-4 http://doi.org/10.1186/s13148-017-0425-4
张苗苗 , 余辉 , 陈庆 , 等 . SEPT9 基因在肿瘤中的研究进展 [J ] . 国际检验医学杂志 , 2019 , 40 ( 4 ): 453 - 458 .
ZHANG M M , YU H , CHEN Q , et al. Research progress of SEPT 9 gene in tumor [J ] . Int J Lab Med , 2019 , 40 ( 4 ): 453 - 458 .
王炳龙 , 汤纪丰 , 俞子晴 , 等 . 血浆 Septin 9基因甲基化检测在胃肠道病变中的临床应用价值评价 [J ] . 临床检验杂志 , 2021 , 39 ( 3 ): 182 - 187 .
WANG B L , TANG J F , YU Z Q , et al. Evaluation for clinical application of methylated Septin 9 test in plasma of gastrointestinal diseases [J ] . Chin J Clin Lab Sci , 2021 , 39 ( 3 ): 182 - 187 .
贺娜 , 冯巩 , 钱美睿 , 等 . 血浆甲基化 Septin 9基因在胃癌患者中的表达和临床意义 [J ] . 中华消化杂志 , 2019 , 39 ( 11 ): 741 - 745 .
HE N , FENG G , QIAN M R , et al. Expression and clinical significance of plasma methylated Septin 9 gene in patients with gastric cancer [J ] . Chin J Dig , 2019 , 39 ( 11 ): 741 - 745 .
刁艳君 , 王娟 , 郝晓柯 . ctDNA甲基化检测在肿瘤诊疗中的价值 [J ] . 中华检验医学杂志 , 2019 , 42 ( 1 ): 1 - 4 .
DIAO Y J , WANG J , HAO X K . The value of methylated circulating tumor DNA as biomarkers in cancer diagnosis and prognosis [J ] . Chin J Lab Med , 2019 , 42 ( 1 ): 1 - 4 .
JIANG H Q , YU Q , CHEN X N , et al. Role of blood m SEPT 9 in evaluating tumor burden and disease monitoring in colorectal cancer patients [J ] . J Clin Lab Anal , 2021 , 35 ( 11 ): e24030 .
PENG X M , LIU X L , XU L , et al. The mSHOX2 is capable of assessing the therapeutic effect and predicting the prognosis of stage Ⅳ lung cancer [J ] . J Thorac Dis , 2019 , 11 ( 6 ): 2458 - 2469 . DOI: 10.21037/jtd http://doi.org/10.21037/jtd http://jtd.amegroups.com/ http://jtd.amegroups.com/
PANAGOPOULOU M , KARAGLANI M , BALGKOURANIDOU I , et al. Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers [J ] . Oncogene , 2019 , 38 ( 18 ): 3387 - 3401 . DOI: 10.1038/s41388-018-0660-y http://doi.org/10.1038/s41388-018-0660-y
0
浏览量
1734
下载量
0
CSCD
- 网络PDF下载
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
AI问答- 技术支持由北京北大方正电子有限公司提供 京ICP备09064830号-19
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies